Despite a rocky Q1 start to 2025 with a 4.3% market drop, AbbVie managed to thrive amid economic unease and shifting investor ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P ...